By Drug Target Review2026-01-20T13:30:29
Scientists have developed the first fully synthetic method for building and reprogramming bacteriophages, offering a faster and safer route to designing virus-based treatments for drug-resistant bacteria.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-03-31T14:05:00Z
2026-03-30T09:54:00Z
2025-10-22T14:00:00
Sponsored by Wuxi Biologics
2026-03-11T14:00:00
Sponsored by Merck
2025-09-18T12:00:00
Sponsored by Benchling
2023-05-18T10:39:07
Sponsored by BPS Bioscience
2024-02-01T12:06:43
Sponsored by Leica Microsystems
2024-01-09T09:30:19
Sponsored by Sartorius
Site powered by Webvision Cloud